Randomized, placebo-controlled, phase II trial of EGFR and COX-2 inhibition in advanced non-small cell lung cancer

被引：0
|
作者：
Reckamp, K. L.
Koczywas, M.
Cristea, M. C.
Dowell, J.
Gardner, B.
Milne, G.
Rad, S. Fouladi
Figlin, R. A.
Elashoff, R.
Dubinett, S. M.
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Vanderbilt Univ, Nashville, TN 37235 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps337
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS337
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A randomized phase II trial of olaparib maintenance versus placebo monotherapy in patients with chemosensitive advanced non-small cell lung cancer.
    Fennell, Dean A.
    Lester, Jason Francis
    Danson, Sarah
    Blackhall, Fiona Helen
    Nicolson, Marianne
    Nixon, Lisette Sheena
    Porter, Catharine
    Gardner, Georgina Mary
    White, Ann
    Griffiths, Gareth Owen
    Casbard, Angela Claire
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Results of a Phase II Placebo-controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non-small-cell Lung Carcinoma
    Hellerstedt, Beth A.
    Vogelzang, Nicholas J.
    Kluger, Harriet M.
    Yasenchak, Christopher A.
    Aftab, Dana T.
    Ramies, David A.
    Gordon, Michael S.
    Lara, Primo, Jr.
    CLINICAL LUNG CANCER, 2019, 20 (02) : 74 - +
  • [23] Erratum to: EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features
    Feng Li
    Yongmei Liu
    Huijiao Chen
    Dianying Liao
    Yali Shen
    Feng Xu
    Jin Wang
    Journal of Experimental & Clinical Cancer Research, 30
  • [24] Cyclooxygenase-2 (COX-2) inhibition with meloxicam in combination with paclitaxel and carboplatin in advanced non-small cell lung cancer (NSCLC).
    Takahashi, T
    Ueda, S
    Ebisawa, M
    Asai, G
    Yamamoto, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 686S - 686S
  • [25] Cox-2 in non-small cell lung cancer: A meta-analysis
    Jiang, Hao
    Wang, Jing
    Zhao, Wei
    CLINICA CHIMICA ACTA, 2013, 419 : 26 - 32
  • [26] Revisiting the role of COX-2 inhibitor for non-small cell lung cancer
    Yokouchi, Hiroshi
    Kanazawa, Kenya
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (05) : 660 - 664
  • [27] A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
    J J Yang
    Q Zhou
    H H Yan
    X C Zhang
    H J Chen
    H Y Tu
    Z Wang
    C R Xu
    J Su
    B C Wang
    B Y Jiang
    X Y Bai
    W Z Zhong
    X N Yang
    Y L Wu
    British Journal of Cancer, 2017, 116 : 568 - 574
  • [28] A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
    Yang, J. J.
    Zhou, Q.
    Yan, H. H.
    Zhang, X. C.
    Chen, H. J.
    Tu, H. Y.
    Wang, Z.
    Xu, C. R.
    Su, J.
    Wang, B. C.
    Jiang, B. Y.
    Bai, X. Y.
    Zhong, W. Z.
    Yang, X. N.
    Wu, Y. L.
    BRITISH JOURNAL OF CANCER, 2017, 116 (05) : 568 - 574
  • [29] Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer
    Spigel, David R.
    Burris, Howard A., III
    Greco, F. Anthony
    Shipley, Dianna L.
    Friedman, Elke K.
    Waterhouse, David M.
    Whorf, Robert C.
    Mitchell, R. Brian
    Daniel, Davey B.
    Zangmeister, Jeffrey
    Bass, J. David
    Hainsworth, John D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) : 2582 - 2589
  • [30] A randomized double-blind placebo-controlled phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancer
    Spigel, David R.
    Anthony, Greco F.
    Burris, I. I. I. Howard A.
    Shipley, Dianna L.
    Friedman, Elke K.
    Waterhouse, David M.
    Whorf, Robert C.
    Mitchell, Brian R.
    Daniel, Davey B.
    Zangmeister, Jeffery
    Sarnoff, Vicki
    Hainsworth, John D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S355 - S355
12345